View Older Stories View More Recent Stories
-
Bristol-Myers Squibb's (BMY) Call Didn't Alleviate Concerns - BMO
-
Sienna Biopharmaceuticals (SNNA) IPO Opens Sharply Higher
-
Vertex Pharma (VRTX): Orkambi Beat Offset By Spending - BMO
-
F5 Networks (FFIV): Staying On The Sidelines - BMO
-
Facebook (FB): Messenger Monetization Begins - BMO
-
Gilead Sciences (GILD): Raising PT To $82 - BMO
-
Mitel Networks (MITL) to acquire ShoreTel (SHOR) for $7.50/Share
-
Mitel announces definitive agreement to acquire ShoreTel
-
Sienna Biopharmaceuticals (SNNA) Prices 4.33M Share IPO at $15/Sh
-
Sienna Biopharmaceuticals, Inc. Announces Pricing of Initial Public Offering of Common Stock
-
Goldcorp Reports Second Quarter 2017 Results
-
Tetraphase Pharma (TTPH) Reports $60M Offering of Common Stock
-
UMH Properties, Inc. Closes Public Offering of 5,000,000 Shares of 6.75% Series C Cumulative Redeemable Preferred Stock
-
Tetraphase Announces Proposed Public Offering of Common Stock
-
Sun Communities, Inc. Reports 2017 Second Quarter Results
-
ULTA Salon (ULTA) Reaction to Violet Grey/Amazon 'Overdone', BMO Says
-
Biogen (BIIB) PT Raised to $328 at BMO Capital; '2Q17 Couldn’t Have Been Better Operationally'
-
Chegg (CHGG) PT Raised to $18 at BMO Capital on 2Q Report; 'Strong Growth Driving Gross Margin Expansion'
-
McDonald's (MCD) PT Raised to $175 at BMO Capital on 2Q; 'Momentum Building Behind Signature Quarter'
-
Interpublic Group (IPG) PT Lowered to $26 at BMO Capital on 2Q Reports
-
Seagate Technology (STX) PT Lowered to $35 at BMO Capital on 4Q Report; 'Market & Operational Issues Amid Management Change'
-
StreetInsider.com Premium Hot Research Recap 7/26
-
UPDATE: BMO Capital Upgrades C.H. Robinson Worldwide (CHRW) to Outperform
-
UPDATE: BMO Capital Downgrades AMD (AMD) to Market Perform
-
Encana Completes Sale of Its Piceance Natural Gas Assets
-
Eli Lilly & Co. (LLY): Stock Remains Overvalued - BMO
-
Tetraphase Pharmaceuticals (TTPH) PT Raised to $13 at BMO Capital
-
BMO Capital Downgrades Amgen (AMGN) to Market Perform
-
Calyxt Announces Full Exercise of Over-Allotment Option and Closing of its Initial Public Offering
-
Cellectis S.A.: Calyxt Announces Full Exercise of Over-Allotment Option and Closing of its Initial Public Offering
-
Ionis Pharmaceuticals (IONS) PT Raised to $67 at BMO Capital; Buy on Weakness
-
StreetInsider.com Premium Hot Research Recap 7/25
-
Ionis (IONS) Partner Biogen Reports Blow-Out Spinraza Sales - BMO Capital
-
QEP Resources (QEP) to Sell Natural Gas Assets In Southwest Wyoming for $777.5M
-
QEP Resources Announces Agreements to Sell Natural Gas Assets In Southwest Wyoming for $777.5 Million
-
Fifth Third Bancorp (FITB) PT Raised to $28 at BMO Capital on 2Q Report; 'Capital Return Is Now a Bigger Part of the Story'
-
Kansas City Southern (KSU) PT Raised to $105 at BMO Capital; 'Q217 Results Ahead of Expectations, Valuation Balanced'
-
Citizens Financial Group (CFG) PT Raised to $39 at BMO Capital on 2Q Report; 'Beat Driven by Lower Credit Costs & Better Fee Income'
-
Huntington Bancshares (HBAN) PT Lowered to $15 at BMO Capital on 2Q Report; 'Expenses Disappoint Again, but Loan Growth Should Pick Up'
-
Gentex (GNTX) PT Lowered to $22 at BMO Capital on 2Q Report; 'Oversold Following 2Q Miss, Outlook Remains Strong'
-
Merck (MRK) PT Lowered to $73 at BMO Capital Ahead of 2Q Announcement on 7/28 BMO; '2Q Should be In-Line'
-
StreetInsider.com Premium Hot Notes Recap 7/24
-
BMO Capital Upgrades Caterpillar (CAT) to Outperform
-
Global Medical REIT Inc. Announces Closing of Over-Allotment Option from Recent Common Stock Offering
-
UMH Properties, Inc. Prices Public Offering of 5,000,000 Shares of 6.75% Series C Cumulative Redeemable Preferred Stock
-
eBay (EBAY): Still Waiting For Inflection - BMO
-
Calyxt (CLXT) IPO Opens, Trades Higher
-
Morgan Stanley (MS) PT Raised to $61 at BMO Capital on 2Q Beat; 'Raising EstimatesFollowing Impressive Top-Line Beat'
-
UMH Properties, Inc. Announces Offering of Series C Cumulative Redeemable Preferred Stock
-
Qualcomm (QCOM): Significant Headwinds Remain - BMO

